Chemkart India Investor Presentation: Key Takeaways
H1 FY27 consolidated revenue ₹205.9 Cr (+99.4% YoY), EBITDA ₹29.4 Cr (14.3% margin), PAT ₹22.6 Cr (11.0%). EZRM SEZ CDMO facility under construction.
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
30 announcements with these filters
H1 FY27 consolidated revenue ₹205.9 Cr (+99.4% YoY), EBITDA ₹29.4 Cr (14.3% margin), PAT ₹22.6 Cr (11.0%). EZRM SEZ CDMO facility under construction.
Chemkart India reported no IPO fund deviation for the half year ended 30 September 2026. Rs.39.48 Crore of Rs.64.47 Crore allocation is utilised.
Chemkart India Ltd reported revenue from operations of ₹205.9 Cr (+99.5% YoY) and net profit of ₹22.6 Cr (+121.6% YoY) for H1 FY27.
Chemkart invests Rs. 0.98 Crore in its WOS Easy Raw Materials for working capital. The related-party transaction was approved at arm's length on 27 October 2026.
Chemkart India invests Rs. 0.98 Crore in its wholly-owned subsidiary Easy Raw Materials via a rights issue. The funds support commissioning of the subsidiary's manufacturing unit.
Chemkart India Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026. The disclosure provides details of shareholder categories and promoter holdings.
Chemkart India Limited has scheduled a board meeting for October 30, 2026, to consider and approve the standalone and consolidated financial results for the half year.
Chemkart India Limited submitted the Regulation 74(5) compliance certificate for the quarter ended 30th September 2026, confirming no share rematerialisation or dematerialisation requests were received.
Chemkart India Ltd promoter Ankit Shailesh Mehta acquired 1,200 equity shares via market purchase. This increases the promoter's stake to 36.92%.
Chemkart India Limited successfully concluded its 7th Annual General Meeting on September 19, 2026. The meeting transacted all business items set out in the notice.
Chemkart India acquired additional shares in its WOS Easy Raw Materials Pvt Ltd for Rs. 1.30 Crore cash. The investment utilises IPO proceeds for subsidiary working capital.
Chemkart India invested Rs. 1.30 Crore in its wholly-owned subsidiary Easy Raw Materials via rights issue. The infusion supports commissioning of the subsidiary's manufacturing unit.
Promoter and Director Ankit Shailesh Mehta acquired 4,800 equity shares of Chemkart India Ltd from the market for ₹0.07 Crore.
Chemkart India's Board accepted CFO Basavaraj Shankar Dalawai's resignation and appointed Mohammad Asim Siddiqui as the new CFO and Whole-Time KMP. The change, effective 11 September 2026, follows internal restructuring.
Chemkart India has issued a revised Annual Report for the financial year 2025-26 to rectify an inadvertent oversight.
Chemkart India Limited has filed its 7th Annual Report for the financial year 2025-26 as required under SEBI (LODR) Regulations, 2015. The report details the company's annual performance.
Chemkart India Limited has scheduled its 7th Annual General Meeting for 19th September 2026 via video conferencing to transact ordinary and special business.
Chemkart India Limited appointed Prem Chand Jain & Co. as Statutory Auditor and Nirmal Tiwari & Associates as Secretarial Auditor. Both appointments are for 60-month terms.
Chemkart India Limited announced its 7th Annual General Meeting for September 19, 2026. The board also appointed new statutory and secretarial auditors for five-year terms.
Chemkart India Limited submitted its Monitoring Agency Report for the quarter ended 30th June 2026 regarding IPO proceeds utilisation.
Chemkart India Ltd invested ₹1.00 Crore in its wholly-owned subsidiary, Easy Raw Materials Private Limited, through a rights issue to fund manufacturing unit commissioning.
Chemkart India reported Q1 FY27 revenue of Rs. 99.60 Crore. The company added 15 new customers and has 20 R&D projects in its pipeline.
Promoter Jaini Shailesh Mehta acquired 1,200 Chemkart shares, representing a 0.01% stake. The transaction is disclosed under SEBI PIT regulations.
Promoter Shailesh Mehta bought 1,800 shares via open market. His stake rose from 1.17% to 1.19%, a 0.02% increase.
Promoter Shailesh Vinodrai Mehta acquired 10,800 equity shares via open market on June 24, 2026. His total shareholding increased to 1.17%.
Promoter Shailesh Vinodrai Mehta acquired 10,800 equity shares on-market for ₹0.15 Crore. This transaction increased his total shareholding to 1.17%.
Chemkart reported H2-FY26 consolidated revenue of ₹11,160.4 Lacs (up 23.8% YoY) and PAT of ₹950.3 Lacs (up 6.8% YoY). Transitioning from trading to manufacturing via a new SEZ facility.
Chemkart India Limited confirmed zero deviation in utilizing ₹64.48 Crore IPO proceeds for the half-year ended March 2026. Funds were deployed for capital expenditure and debt repayment.
Chemkart India Ltd reported revenue from operations of ₹111.6 Cr (+23.7% YoY) and net profit of ₹9.5 Cr (+6.7% YoY) for H2 FY26.
Chemkart India reported consolidated annual revenue of ₹214.83 Crore for FY2026. The Board also appointed new internal and secretarial auditors to strengthen corporate governance.